Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Tumor-Agnostic 3Thoracic 3Head & Neck 3Genitourinary 3Other solid neoplasm 2Gynecologic 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1NET 1Myeloid 1Lymphoid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Neoplasm Metastasis 5Neoplasms 3

Interventions

Surveys and Questionnaires 65pembrolizumab 56Gemcitabine 54Paclitaxel 51Blood Specimen Collection 45Carboplatin 44Bevacizumab 41Docetaxel 38Cisplatin 33Nivolumab 32Fluorouracil 31Capecitabine 28Radiotherapy 25Pemetrexed 25Irinotecan 25Standard of Care 24Interviews as Topic 24Magnetic Resonance Spectroscopy 23Leucovorin 22Erlotinib Hydrochloride 22atezolizumab 21Cetuximab 21Afatinib 21Oxaliplatin 19trametinib 18Exercise 18Ipilimumab 17Sorafenib 16Cyclophosphamide 16olaparib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Immunotherapy × Tumor-Agnostic × Clear all
NCT06163053 2026-01-14

A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home

Bristol-Myers Squibb

Completed
49 enrolled
Tumor-Agnostic

Neoplasms

NCT06831136 2025-09-10

PANCARDINAL-2

The University of Texas Health Science Center, Houston

Phase 2 Recruiting
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT02783885 2016-05-26

Clinical Utilization of Newly Approved Oncology Medications

National Guard Health Affairs

Unknown
100 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡